A cost-effectiveness analysis of neonatal ECMO using existing evidence.
A cost-effectiveness analysis is part of the U.K. ECMO Trial. In preparation for this analysis, existing evidence on the costs and effectiveness of neonatal ECMO was evaluated. ECMO appears to be more costly but may be more or less effective than conventional treatment. No case can be made for introducing ECMO before trial results are available.
Howard
S
S
London School of Hygiene and Tropical Medicine.
Mugford
M
M
Normand
C
C
Elbourne
D
D
Grant
A
A
Field
D
D
Johnson
A
A
D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D004739:England; D015199:Extracorporeal Membrane Oxygenation / Q000191:economics*; D006285:Health Planning; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal; D012131:Respiratory Insufficiency / Q000191:economics / Q000401:mortality / Q000628:therapy*; D012606:Scotland; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome